Pulmatrix Inc (PULM)

NASDAQ
4.5900
+0.0400(+0.88%)
  • Volume:
    16,036
  • Day's Range:
    4.3800 - 4.6688
  • 52 wk Range:
    4.0324 - 20.8000

PULM Overview

Prev. Close
4.55
Day's Range
4.38-4.6688
Revenue
4.94M
Open
4.41
52 wk Range
4.0324-20.8
EPS
-8.3
Volume
16,036
Market Cap
15.55M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
17,071
P/E Ratio
-
Beta
1.12
1-Year Change
-77.93%
Shares Outstanding
3,387,172
Next Earnings Date
09 Aug 2022
What is your sentiment on Pulmatrix?
or
Market is currently closed. Voting is open during market hours.

Pulmatrix Inc News

Pulmatrix Inc Company Profile

Pulmatrix Inc Company Profile

Employees
25

Pulmatrix, Inc. is a clinical-stage biotechnology company, which is focused on the discovery and development of inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs. It designs and develops inhaled therapeutic products based on its dry powder delivery technology, inhaled small particles easily respirable and emitted (iSPERSE), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways. iSPERSE’s lead development program, Pulmazole is its inhaled formulation of itraconazole, an anti-fungal drug commercially available as an oral drug, which it is developing to treat and prevent pulmonary fungal infections. PUR1800 is developing for the treatment of acute exacerbations of chronic obstructive pulmonary disease and PUR3100 is developing for the treatment of acute migraine.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuySellSellStrong Sell
Technical IndicatorsBuyBuyNeutralStrong SellStrong Sell
SummaryBuyBuyNeutralStrong SellStrong Sell